Phase III News
Most Popular Phase III Story
Osiris hits milestone with stem cell trial
Osiris Therapeutics has hit a notable milestone, completing enrollment for a late-stage stem cell trial. Researchers will explore the benefits of Prochymal for steroid-refractory acute Graft versus... Read more...
Latest Headlines
- December 23, 2008
- December 15, 2008
- December 8, 2008
- November 4, 2008
- October 27, 2008
- October 27, 2008
- October 14, 2008
- October 7, 2008
- August 20, 2008
- August 19, 2008
- August 18, 2008
- August 12, 2008
- June 13, 2008
- June 12, 2008
- June 10, 2008
- June 4, 2008
- June 4, 2008
- May 30, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
